{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T13:02:33Z","timestamp":1782824553383,"version":"3.54.5"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"vor","delay-in-days":24,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["113-2314-B-038-021"],"award-info":[{"award-number":["113-2314-B-038-021"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["111-2314-B-016-049"],"award-info":[{"award-number":["111-2314-B-016-049"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004700","name":"Taipei Medical University","doi-asserted-by":"publisher","award":["TMU112-AE1-B08"],"award-info":[{"award-number":["TMU112-AE1-B08"]}],"id":[{"id":"10.13039\/501100004700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010425","name":"Tri-Service General Hospital","doi-asserted-by":"publisher","award":["VTA113-T-5-1\/VTA114-T-2-1"],"award-info":[{"award-number":["VTA113-T-5-1\/VTA114-T-2-1"]}],"id":[{"id":"10.13039\/501100010425","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Cell Int"],"DOI":"10.1186\/s12935-025-04118-w","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T18:34:49Z","timestamp":1769193289000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Interferon-\u03b1 enhances NK cell function to counteract autologous platelet-mediated tumor immune evasion"],"prefix":"10.1186","volume":"26","author":[{"given":"Li-Tzu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Chin","family":"Shih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Hong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Feng","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiu-Lung","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teng-Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Wen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Krupalakshmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Fei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Lueng","family":"Shih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsai-Yuan","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Yen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Chen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,23]]},"reference":[{"issue":"6","key":"4118_CR1","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1016\/j.cell.2020.02.029","volume":"180","author":"A Crinier","year":"2020","unstructured":"Crinier A, Narni-Mancinelli E, Ugolini S, Vivier E. SnapShot: natural killer cells. Cell. 2020;180(6):1280\u20131280. e1281.","journal-title":"Cell"},{"issue":"7","key":"4118_CR2","doi-asserted-by":"publisher","first-page":"e626","DOI":"10.1002\/mco2.626","volume":"5","author":"D Wang","year":"2024","unstructured":"Wang D, Dou L, Sui L, Xue Y, Xu S. Natural killer cells in cancer immunotherapy. MedComm (2020). 2024;5(7):e626.","journal-title":"MedComm (2020)"},{"issue":"2","key":"4118_CR3","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s41577-021-00558-3","volume":"22","author":"NK Bjorkstrom","year":"2022","unstructured":"Bjorkstrom NK, Strunz B, Ljunggren HG. Natural killer cells in antiviral immunity. Nat Rev Immunol. 2022;22(2):112\u201323.","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"4118_CR4","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/s41577-022-00732-1","volume":"23","author":"NK Wolf","year":"2023","unstructured":"Wolf NK, Kissiov DU, Raulet DH. Roles of natural killer cells in immunity to cancer, and applications to immunotherapy. Nat Rev Immunol. 2023;23(2):90\u2013105.","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"4118_CR5","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.blre.2014.10.003","volume":"29","author":"EM Golebiewska","year":"2015","unstructured":"Golebiewska EM, Poole AW. Platelet secretion: from haemostasis to wound healing and beyond. Blood Rev. 2015;29(3):153\u201362.","journal-title":"Blood Rev"},{"issue":"23","key":"4118_CR6","doi-asserted-by":"publisher","first-page":"3174","DOI":"10.1182\/blood.2019003976","volume":"137","author":"HG Roweth","year":"2021","unstructured":"Roweth HG, Battinelli EM. Lessons to learn from tumor-educated platelets. Blood. 2021;137(23):3174\u201380.","journal-title":"Blood"},{"issue":"4","key":"4118_CR7","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1111\/j.1538-7836.2006.01817.x","volume":"4","author":"N Li","year":"2006","unstructured":"Li N, Ji Q, Hjemdahl P. Platelet-lymphocyte conjugation differs between lymphocyte subpopulations. J Thromb Haemost. 2006;4(4):874\u201381.","journal-title":"J Thromb Haemost"},{"issue":"3","key":"4118_CR8","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/0165-5728(92)90005-6","volume":"37","author":"J Gabrilovac","year":"1992","unstructured":"Gabrilovac J, Cicin-Sain L, Osmak M, Jernej B. Alteration of NK- and ADCC-activities in rats genetically selected for low or high platelet serotonin level. J Neuroimmunol. 1992;37(3):213\u201322.","journal-title":"J Neuroimmunol"},{"issue":"3","key":"4118_CR9","doi-asserted-by":"publisher","first-page":"869","DOI":"10.4049\/jimmunol.139.3.869","volume":"139","author":"K Hellstrand","year":"1987","unstructured":"Hellstrand K, Hermodsson S. Role of serotonin in the regulation of human natural killer cell cytotoxicity. J Immunol. 1987;139(3):869\u201375.","journal-title":"J Immunol"},{"issue":"2","key":"4118_CR10","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1164\/ajrccm\/144.2.272","volume":"144","author":"M Thivierge","year":"1991","unstructured":"Thivierge M, Rola-Pleszczynski M. Enhancement of pulmonary natural killer cell activity by platelet activating factor. Mechanisms of activation involving Ca2+, protein kinase C, and lipooxygenase products. Am Rev Respir Dis. 1991;144(2):272\u20137.","journal-title":"Am Rev Respir Dis"},{"issue":"3","key":"4118_CR11","first-page":"370","volume":"67","author":"Y Mandi","year":"1989","unstructured":"Mandi Y, Farkas G, Koltai M, Beladi I, Mencia-Huerta JM, Braquet P. The effect of the platelet-activating factor antagonist, BN 52021, on human natural killer cell-mediated cytotoxicity. Immunology. 1989;67(3):370\u20134.","journal-title":"Immunology"},{"issue":"19","key":"4118_CR12","doi-asserted-by":"publisher","first-page":"7775","DOI":"10.1158\/0008-5472.CAN-09-2123","volume":"69","author":"HG Kopp","year":"2009","unstructured":"Kopp HG, Placke T, Salih HR. Platelet-derived transforming growth factor-beta down-regulates NKG2D thereby inhibiting natural killer cell antitumor reactivity. Cancer Res. 2009;69(19):7775\u201383.","journal-title":"Cancer Res"},{"issue":"9","key":"4118_CR13","doi-asserted-by":"publisher","first-page":"2704","DOI":"10.1182\/blood.V82.9.2704.2704","volume":"82","author":"R Vezza","year":"1993","unstructured":"Vezza R, Roberti R, Nenci GG, Gresele P. Prostaglandin E2 potentiates platelet aggregation by priming protein kinase C. Blood. 1993;82(9):2704\u201313.","journal-title":"Blood"},{"issue":"Suppl 1","key":"4118_CR14","doi-asserted-by":"publisher","first-page":"S43","DOI":"10.1053\/j.seminhematol.2013.03.018","volume":"50","author":"T Nishimoto","year":"2013","unstructured":"Nishimoto T, Kuwana M. CD4\u2009+\u2009CD25\u2009+\u2009Foxp3\u2009+\u2009regulatory T cells in the pathophysiology of immune thrombocytopenia. Semin Hematol. 2013;50(Suppl 1):S43\u201349.","journal-title":"Semin Hematol"},{"issue":"2","key":"4118_CR15","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1158\/0008-5472.CAN-11-1872","volume":"72","author":"T Placke","year":"2012","unstructured":"Placke T, Orgel M, Schaller M, Jung G, Rammensee HG, Kopp HG, Salih HR. Platelet-derived MHC class I confers a pseudonormal phenotype to cancer cells that subverts the antitumor reactivity of natural killer immune cells. Cancer Res. 2012;72(2):440\u20138.","journal-title":"Cancer Res"},{"issue":"5","key":"4118_CR16","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.4049\/jimmunol.1502658","volume":"197","author":"S Sadallah","year":"2016","unstructured":"Sadallah S, Schmied L, Eken C, Charoudeh HN, Amicarella F, Schifferli JA. Platelet-derived ectosomes reduce NK cell function. J Immunol. 2016;197(5):1663\u201371.","journal-title":"J Immunol"},{"issue":"2","key":"4118_CR17","doi-asserted-by":"publisher","first-page":"e1364827","DOI":"10.1080\/2162402X.2017.1364827","volume":"7","author":"S Maurer","year":"2018","unstructured":"Maurer S, Kropp KN, Klein G, Steinle A, Haen SP, Walz JS, Hinterleitner C, Marklin M, Kopp HG, Salih HR. Platelet-mediated shedding of NKG2D ligands impairs NK cell immune-surveillance of tumor cells. Oncoimmunology. 2018;7(2):e1364827.","journal-title":"Oncoimmunology"},{"issue":"8","key":"4118_CR18","doi-asserted-by":"publisher","first-page":"e948705","DOI":"10.4161\/21624011.2014.948705","volume":"3","author":"NR Comet","year":"2014","unstructured":"Comet NR, Aguilo JI, Rathore MG, Catalan E, Garaude J, Uze G, Naval J, Pardo J, Villalba M, Anel A. IFNalpha signaling through PKC-theta is essential for antitumor NK cell function. Oncoimmunology. 2014;3(8):e948705.","journal-title":"Oncoimmunology"},{"key":"4118_CR19","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s40164-017-0081-6","volume":"6","author":"L Zhang","year":"2017","unstructured":"Zhang L, Tai YT, Ho MZG, Qiu L, Anderson KC. Interferon-alpha-based immunotherapies in the treatment of B cell-derived hematologic neoplasms in today\u2019s treat-to-target era. Exp Hematol Oncol. 2017;6:20.","journal-title":"Exp Hematol Oncol"},{"issue":"2","key":"4118_CR20","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.jhep.2012.09.029","volume":"58","author":"L Micco","year":"2013","unstructured":"Micco L, Peppa D, Loggi E, Schurich A, Jefferson L, Cursaro C, Panno AM, Bernardi M, Brander C, Bihl F, et al. Differential boosting of innate and adaptive antiviral responses during pegylated-interferon-alpha therapy of chronic hepatitis B. J Hepatol. 2013;58(2):225\u201333.","journal-title":"J Hepatol"},{"issue":"2","key":"4118_CR21","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1084\/jem.20150712","volume":"213","author":"S Madera","year":"2016","unstructured":"Madera S, Rapp M, Firth MA, Beilke JN, Lanier LL, Sun JC. Type I IFN promotes NK cell expansion during viral infection by protecting NK cells against fratricide. J Exp Med. 2016;213(2):225\u201333.","journal-title":"J Exp Med"},{"issue":"1","key":"4118_CR22","doi-asserted-by":"publisher","first-page":"2864","DOI":"10.1038\/s41598-023-29450-x","volume":"13","author":"K Garofano","year":"2023","unstructured":"Garofano K, Rashid K, Smith M, Brantner C, Suwunnakorn S, Diemert D, Gordon O, Horvath A, Khan S, Popratiloff A, et al. Prostate cancer cell-platelet bidirectional signaling promotes calcium mobilization, invasion and apoptotic resistance via distinct receptor-ligand pairs. Sci Rep. 2023;13(1):2864.","journal-title":"Sci Rep"},{"key":"4118_CR23","first-page":"687","volume":"7","author":"G Moncayo","year":"2016","unstructured":"Moncayo G, Lin D, McCarthy MT, Watson AA, O\u2019Callaghan CA. MICA expression is regulated by cell adhesion and contact in a FAK\/Src-Dependent manner. Front Immunol. 2016;7:687.","journal-title":"Front Immunol"},{"issue":"10","key":"4118_CR24","first-page":"3528","volume":"6","author":"S Jakfar","year":"2021","unstructured":"Jakfar S, Lin TC, Wu SC, Wang YH, Sun YJ, Thacker M, Liu LX, Lin FH. New design to remove leukocytes from platelet-rich plasma (PRP) based on cell dimension rather than density. Bioact Mater. 2021;6(10):3528\u201340.","journal-title":"Bioact Mater"},{"key":"4118_CR25","doi-asserted-by":"publisher","unstructured":"Jakfar S, Ningsih DS, Lin TC, Chen ZY, Lin FH, Gani BA, Syafriza D, Kusuma H. Evaluation of a membrane filter and platelet-rich plasma (PRP) product obtained from a prototype PRP kit that works through a new method for separating PRP based on cell dimensions. AIP Adv. 2024;14(1):015305. https:\/\/doi.org\/10.1063\/5.0176510","DOI":"10.1063\/5.0176510"},{"issue":"13","key":"4118_CR26","doi-asserted-by":"publisher","first-page":"108188","DOI":"10.1016\/j.celrep.2020.108188","volume":"32","author":"LT Wang","year":"2020","unstructured":"Wang LT, Wang HH, Chiang HC, Huang LY, Chiu SK, Siu LK, Liu KJ, Yen ML, Yen BL. Human placental MSC-Secreted IL-1beta enhances neutrophil bactericidal functions during hypervirulent Klebsiella infection. Cell Rep. 2020;32(13):108188.","journal-title":"Cell Rep"},{"issue":"3","key":"4118_CR27","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.4049\/jimmunol.1601313","volume":"198","author":"WC Huang","year":"2017","unstructured":"Huang WC, Easom NJ, Tang XZ, Gill US, Singh H, Robertson F, Chang C, Trowsdale J, Davidson BR, Rosenberg WM, et al. T cells infiltrating diseased liver express ligands for the NKG2D stress surveillance system. J Immunol. 2017;198(3):1172\u201382.","journal-title":"J Immunol"},{"issue":"1","key":"4118_CR28","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","volume":"10","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, Zhou B, Pache L, Chang M, Khodabakhshi AH, Tanaseichuk O, Benner C, Chanda SK. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019;10(1):1523.","journal-title":"Nat Commun"},{"key":"4118_CR29","doi-asserted-by":"publisher","unstructured":"Wang LT, Yen BL, Wang HH, Chao YY, Lee W, Huang LY, Chiu SK, Siu LK, Liu KJ, Sytwu HK, et al. Placental mesenchymal stem cells boost M2 alveolar over M1 bone marrow macrophages via IL-1\u03b2 in Klebsiella-mediated acute respiratory distress syndrome. Thorax. 2022;78(5):504\u2013514.https:\/\/doi.org\/10.1136\/thoraxjnl-2021-217928","DOI":"10.1136\/thoraxjnl-2021-217928"},{"issue":"1","key":"4118_CR30","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.bbrc.2005.11.025","volume":"339","author":"H Ogbomo","year":"2006","unstructured":"Ogbomo H, Hahn A, Geiler J, Michaelis M, Doerr HW, Cinatl J Jr. NK sensitivity of neuroblastoma cells determined by a highly sensitive coupled luminescent method. Biochem Biophys Res Commun. 2006;339(1):375\u20139.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"4118_CR31","doi-asserted-by":"publisher","first-page":"10300","DOI":"10.1038\/s41598-018-28211-5","volume":"8","author":"TA Blair","year":"2018","unstructured":"Blair TA, Michelson AD, Frelinger AL. 3rd: mass cytometry reveals distinct platelet subtypes in healthy subjects and novel alterations in surface glycoproteins in Glanzmann thrombasthenia. Sci Rep. 2018;8(1):10300.","journal-title":"Sci Rep"},{"key":"4118_CR32","doi-asserted-by":"publisher","first-page":"640578","DOI":"10.3389\/fimmu.2021.640578","volume":"12","author":"L Schmied","year":"2021","unstructured":"Schmied L, Hoglund P, Meinke S. Platelet-Mediated protection of cancer cells from immune Surveillance - Possible implications for cancer immunotherapy. Front Immunol. 2021;12:640578.","journal-title":"Front Immunol"},{"key":"4118_CR33","doi-asserted-by":"publisher","first-page":"847","DOI":"10.3389\/fimmu.2018.00847","volume":"9","author":"F Castro","year":"2018","unstructured":"Castro F, Cardoso AP, Goncalves RM, Serre K, Oliveira MJ. Interferon-Gamma at the crossroads of tumor immune surveillance or evasion. Front Immunol. 2018;9:847.","journal-title":"Front Immunol"},{"issue":"5","key":"4118_CR34","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/ni1582","volume":"9","author":"E Vivier","year":"2008","unstructured":"Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S. Functions of natural killer cells. Nat Immunol. 2008;9(5):503\u201310.","journal-title":"Nat Immunol"},{"issue":"1\u20132","key":"4118_CR35","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jim.2004.08.008","volume":"294","author":"G Alter","year":"2004","unstructured":"Alter G, Malenfant JM, Altfeld M. CD107a as a functional marker for the identification of natural killer cell activity. J Immunol Methods. 2004;294(1\u20132):15\u201322.","journal-title":"J Immunol Methods"},{"issue":"8","key":"4118_CR36","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1182\/blood-2012-07-441832","volume":"122","author":"A Cohnen","year":"2013","unstructured":"Cohnen A, Chiang SC, Stojanovic A, Schmidt H, Claus M, Saftig P, Janssen O, Cerwenka A, Bryceson YT, Watzl C. Surface CD107a\/LAMP-1 protects natural killer cells from degranulation-associated damage. Blood. 2013;122(8):1411\u20138.","journal-title":"Blood"},{"key":"4118_CR37","doi-asserted-by":"publisher","first-page":"608849","DOI":"10.3389\/fimmu.2020.608849","volume":"11","author":"S Maurer","year":"2020","unstructured":"Maurer S, Ferrari de Andrade L. NK cell interaction with platelets and myeloid cells in the tumor milieu. Front Immunol. 2020;11:608849.","journal-title":"Front Immunol"},{"key":"4118_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15072154","author":"A Natoni","year":"2023","unstructured":"Natoni A, Cerreto M, De Propris MS, Petrucci MT, Fazio F, Intoppa S, et al. Sialofucosylation enables platelet binding to myeloma cells via P-selectin and suppresses NK cell-mediated cytotoxicity. Cancers (Basel). 2023;15(7):2154. https:\/\/doi.org\/10.3390\/cancers15072154","journal-title":"Cancers (Basel)"},{"issue":"4","key":"4118_CR39","first-page":"178","volume":"5","author":"DJ Hicklin","year":"1999","unstructured":"Hicklin DJ, Marincola FM, Ferrone S. HLA class I antigen downregulation in human cancers: T-cell immunotherapy revives an old story. Mol Med. 1999;5(4):178\u201386.","journal-title":"Mol Med"},{"key":"4118_CR40","doi-asserted-by":"publisher","first-page":"844866","DOI":"10.3389\/fimmu.2022.844866","volume":"13","author":"BC Taylor","year":"2022","unstructured":"Taylor BC, Balko JM. Mechanisms of MHC-I downregulation and role in immunotherapy response. Front Immunol. 2022;13:844866.","journal-title":"Front Immunol"},{"issue":"4","key":"4118_CR41","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/cmi.2016.26","volume":"14","author":"Y He","year":"2017","unstructured":"He Y, Tian Z. NK cell education via nonclassical MHC and non-MHC ligands. Cell Mol Immunol. 2017;14(4):321\u201330.","journal-title":"Cell Mol Immunol"},{"key":"4118_CR42","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01541-18","author":"AKR Kwaa","year":"2019","unstructured":"Kwaa AKR, Talana CAG, Blankson JN. Interferon alpha enhances NK cell function and the suppressive capacity of HIV-specific CD8(+) T cells. J Virol. 2019;93(3):e01541-18. https:\/\/doi.org\/10.1128\/JVI.01541-18","journal-title":"J Virol"},{"issue":"16","key":"4118_CR43","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1182\/blood-2017-05-743187","volume":"131","author":"XR Xu","year":"2018","unstructured":"Xu XR, Yousef GM, Ni H. Cancer and platelet crosstalk: opportunities and challenges for aspirin and other antiplatelet agents. Blood. 2018;131(16):1777\u201389.","journal-title":"Blood"},{"key":"4118_CR44","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.3389\/fimmu.2017.01124","volume":"8","author":"S Paul","year":"2017","unstructured":"Paul S, Lal G. The molecular mechanism of natural killer cells function and its importance in cancer immunotherapy. Front Immunol. 2017;8:1124.","journal-title":"Front Immunol"},{"key":"4118_CR45","doi-asserted-by":"publisher","first-page":"1165989","DOI":"10.3389\/fimmu.2023.1165989","volume":"14","author":"Y Li","year":"2023","unstructured":"Li Y, Wang H, Zhao Z, Yang Y, Meng Z, Qin L. Effects of the interactions between platelets with other cells in tumor growth and progression. Front Immunol. 2023;14:1165989.","journal-title":"Front Immunol"},{"issue":"13","key":"4118_CR46","doi-asserted-by":"publisher","first-page":"4259","DOI":"10.7150\/ijbs.85986","volume":"19","author":"H Tong","year":"2023","unstructured":"Tong H, Li K, Zhou M, Wu R, Yang H, Peng Z, Zhao Q, Luo KQ. Coculture of cancer cells with platelets increases their survival and metastasis by activating the TGFbeta\/Smad\/PAI-1 and PI3K\/AKT pathways. Int J Biol Sci. 2023;19(13):4259\u201377.","journal-title":"Int J Biol Sci"},{"issue":"1","key":"4118_CR47","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s40364-025-00742-w","volume":"13","author":"M Morales-Pacheco","year":"2025","unstructured":"Morales-Pacheco M, Valenzuela-Mayen M, Gonzalez-Alatriste AM, Mendoza-Almanza G, Cortes-Ramirez SA, Losada-Garcia A, Rodriguez-Martinez G, Gonzalez-Ramirez I, Maldonado-Lagunas V, Vazquez-Santillan K, et al. The role of platelets in cancer: from their influence on tumor progression to their potential use in liquid biopsy. Biomark Res. 2025;13(1):27.","journal-title":"Biomark Res"},{"key":"4118_CR48","doi-asserted-by":"publisher","first-page":"936662","DOI":"10.3389\/fimmu.2022.936662","volume":"13","author":"J Chen","year":"2022","unstructured":"Chen J, Gao X, Shen S, Xu J, Sun Z, Lin R, et al. Association of longitudinal platelet count trajectory with ICU mortality: a multi-cohort study. Front Immunol. 2022;13:936662.","journal-title":"Front Immunol"},{"issue":"1","key":"4118_CR49","doi-asserted-by":"publisher","first-page":"e0262356","DOI":"10.1371\/journal.pone.0262356","volume":"17","author":"JL Velez-Paez","year":"2022","unstructured":"Velez-Paez JL, Legua P, Velez-Paez P, Irigoyen E, Andrade H, Jara A, Lopez F, Perez-Galarza J, Baldeon L. Mean platelet volume and mean platelet volume to platelet count ratio as predictors of severity and mortality in sepsis. PLoS ONE. 2022;17(1):e0262356.","journal-title":"PLoS ONE"},{"issue":"1","key":"4118_CR50","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s40164-025-00676-x","volume":"14","author":"C Cai","year":"2025","unstructured":"Cai C, Liu Y, Lu R, Fan X, Zeng S, Gan P. Platelets in cancer and immunotherapy: functional dynamics and therapeutic opportunities. Exp Hematol Oncol. 2025;14(1):83.","journal-title":"Exp Hematol Oncol"},{"issue":"17","key":"4118_CR51","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.3748\/wjg.v10.i17.2472","volume":"10","author":"SJ Hwang","year":"2004","unstructured":"Hwang SJ, Luo JC, Li CP, Chu CW, Wu JC, Lai CR, Chiang JH, Chau GY, Lui WY, Lee CC, et al. Thrombocytosis: a paraneoplastic syndrome in patients with hepatocellular carcinoma. World J Gastroenterol. 2004;10(17):2472\u20137.","journal-title":"World J Gastroenterol"},{"issue":"2","key":"4118_CR52","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1182\/blood-2014-03-562538","volume":"124","author":"RJ Lin","year":"2014","unstructured":"Lin RJ, Afshar-Kharghan V, Schafer AI. Paraneoplastic thrombocytosis: the secrets of tumor self-promotion. Blood. 2014;124(2):184\u20137.","journal-title":"Blood"},{"issue":"11","key":"4118_CR53","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1056\/NEJMoa1912035","volume":"382","author":"TG Simon","year":"2020","unstructured":"Simon TG, Duberg AS, Aleman S, Chung RT, Chan AT, Ludvigsson JF. Association of aspirin with hepatocellular carcinoma and liver-related mortality. N Engl J Med. 2020;382(11):1018\u201328.","journal-title":"N Engl J Med"},{"key":"4118_CR54","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.3389\/fimmu.2018.01009","volume":"9","author":"NJW Easom","year":"2018","unstructured":"Easom NJW, Stegmann KA, Swadling L, Pallett LJ, Burton AR, Odera D, et al. IL-15 overcomes hepatocellular carcinoma-induced NK cell dysfunction. Front Immunol. 2018;9:1009.","journal-title":"Front Immunol"}],"container-title":["Cancer Cell International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-025-04118-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-025-04118-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-025-04118-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T02:03:16Z","timestamp":1771293796000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12935-025-04118-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,23]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4118"],"URL":"https:\/\/doi.org\/10.1186\/s12935-025-04118-w","relation":{},"ISSN":["1475-2867"],"issn-type":[{"value":"1475-2867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,23]]},"assertion":[{"value":"19 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approval of the research protocol by an Institutional Reviewer Board: Our experiments were approved by the Institutional Review Board of Tri-Service General Hospital (Approval No. C202105122).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"92"}}